	US 11,767,356 B1
	Canine parvovirus nanobody CPV-VHH-E3 and application thereof
Hong Jia, Beijing (CN); Hongfei Zhu, Beijing (CN); Qianqian Feng, Beijing (CN); Zhaoyang Wang, Beijing (CN); Weifeng Yuan, Beijing (CN); and Zhongbao Pang, Beijing (CN)
Assigned to INSTITUTE OF ANIMAL SCIENCES OF CAAS, Beijing (CN)
Filed by Institute of Animal Sciences of CAAS, Beijing (CN)
Filed on Nov. 9, 2022, as Appl. No. 17/983,727.
Claims priority of application No. 202111337192.1 (CN), filed on Nov. 12, 2021.
Int. Cl. C07K 16/08 (2006.01); C12N 15/79 (2006.01); A61K 39/23 (2006.01); A61K 39/00 (2006.01)

CPC C07K 16/084 (2013.01) [C12N 15/79 (2013.01); A61K 39/23 (2013.01); A61K 2039/552 (2013.01); C07K 2317/569 (2013.01)]

4 Claims

1. A canine parvovirus (CPV) nanobody CPV-VHH-E3, comprising a heavy chain variable region with an amino acid sequence as shown in SEQ ID NO: 1.